Neurodegenerative
Disorder Therapeutics
Global Market Report
2021: COVID-19 Growth
And Change To 2030
@The Business Research Company. All rights reserved.
Neurodegenerative Disorder Therapeutics Market
Characteristics:
The global neurodegenerative disorder therapeutics market is expected to grow from $14.08 billion in 2020 to $15.19
billion in 2021 at a compound annual growth rate (CAGR) of 7.9%. The growth is mainly due to the companies resuming
their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to
restrictive containment measures involving social distancing, remote working, and the closure of commercial activities
that resulted in operational challenges. The neurodegenerative disorder therapeutics market is expected to reach
$20.15 billion in 2025 at a CAGR of 7%.
The report covers the Neurodegenerative Disorder Therapeutics market’s segments-
By Indication Type
By Drug Type
By Distribution
Parkinson's Disease,
Alzheimer's Disease,
Multiple Sclerosis,
Huntington Disease
N- methyl- D-
aspartate
Receptor,
Selective
Serotonin
Reuptake Inhibitor
Hospital
Pharmacy, Retail
Pharmacy, Online
Pharmacy
Xx xxxx
Xxxxx, Xxxxxxxx,
Xxxx
Xx xxxx
Xxxxx,
Xxxxxxxx,
Xxxx
Xx xxxx
Xxxxx,
Xxxxxxxx,
Xxxx
@The Business Research Company. All rights reserved.
Neurodegenerative Disorder Therapeutics Global Market
Report 2021 is the most comprehensive report available on
this market and will help gain a truly global perspective as it
covers 60 geographies.
The chapter on the impact of COVID-19 gives valuable
insights on supply chain disruptions, logistical challenges, and
other economic implications of the virus on the market. The
chapter also covers markets which have been positively
affected by the pandemic.
Click Here To View Complete Report
@The Business Research Company. All rights reserved.
Major Key Players
Major companies in the market include
Click Here To Get
A Sample Report
Biogen
Pfizer
Novartis
Sanofi
Teva Pharmaceutical
@The Business